A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
- Currently, Proton Pump Inhibitors and H2Receptor Blockers are widely used by emergency
physicians in Turkey for the treatment of patients with dyspepsia.
- The objective of the study was to assess whether intravenous esomeprazol has superior
dyspeptic pain reduction compared with ranitidine or hydrotalcid in emergency department
(ED) adults
- The investigators second aim was to compare recurrent dyspeptic pain within 24 hours
after discharge and cost of treatments in the treatment of dyspepsia.